Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	benzodiazepine receptor binding	RIMBP3 RIMBP3C RIMBP3B	1.28e-06	5	102	3	GO:0030156
GeneOntologyMolecularFunction	transcription coregulator binding	SP1 MED1 CCNT2 ZNF644 AHR CNOT2	8.27e-05	140	102	6	GO:0001221
GeneOntologyMolecularFunction	ATP-dependent activity, acting on DNA	TTF2 SETX ATRX MCM8 ARID1A	4.89e-04	127	102	5	GO:0008094
GeneOntologyBiologicalProcess	transcription elongation by RNA polymerase II	NELFE INTS12 ZMYND8 MED1 RTF1 CCNT2 CDK13	2.83e-06	127	100	7	GO:0006368
GeneOntologyBiologicalProcess	regulation of transcription elongation by RNA polymerase II	NELFE INTS12 ZMYND8 MED1 CCNT2 CDK13	6.05e-06	93	100	6	GO:0034243
GeneOntologyBiologicalProcess	DNA-templated transcription elongation	NELFE INTS12 ZMYND8 MED1 RTF1 CCNT2 CDK13	6.50e-06	144	100	7	GO:0006354
GeneOntologyBiologicalProcess	regulation of DNA-templated transcription elongation	NELFE INTS12 ZMYND8 MED1 CCNT2 CDK13	1.22e-05	105	100	6	GO:0032784
GeneOntologyBiologicalProcess	embryonic organ development	SP1 HIPK2 MED1 ARID1A HOXA3 FRZB COBL TSHZ1 PLG HECTD1 WDR48	8.69e-05	561	100	11	GO:0048568
GeneOntologyBiologicalProcess	positive regulation of transcription elongation by RNA polymerase II	ZMYND8 MED1 CCNT2 CDK13	1.37e-04	54	100	4	GO:0032968
GeneOntologyBiologicalProcess	embryonic morphogenesis	SP1 CLASP1 HIPK2 SPECC1L MED1 ARID1A RTF1 HOXA3 FRZB COBL TSHZ1 HECTD1	1.73e-04	713	100	12	GO:0048598
GeneOntologyBiologicalProcess	double-strand break repair	UIMC1 SETX ING3 MCM8 ZMYND8 POGZ ARID1A WDR48	1.81e-04	324	100	8	GO:0006302
GeneOntologyCellularComponent	transcription elongation factor complex	NELFE TTF2 ICE1 RTF1 CCNT2 CDK13 AFF1 AFF4	2.85e-10	56	102	8	GO:0008023
GeneOntologyCellularComponent	nuclear body	NELFE PCNP UIMC1 SETX ATRX STAG1 HIPK2 ICE1 NPHP4 SRSF12 UBE2O CDK13 RBM15B ZNF638 HECTD1	3.15e-05	903	102	15	GO:0016604
GeneOntologyCellularComponent	manchette	RIMBP3 RIMBP3C RIMBP3B	3.38e-04	28	102	3	GO:0002177
GeneOntologyCellularComponent	super elongation complex	AFF1 AFF4	3.49e-04	6	102	2	GO:0032783
GeneOntologyCellularComponent	bicellular tight junction	SH3BP1 MPDZ NPHP4 FRMD4A CGNL1	4.59e-04	131	102	5	GO:0005923
GeneOntologyCellularComponent	tight junction	SH3BP1 MPDZ NPHP4 FRMD4A CGNL1	6.01e-04	139	102	5	GO:0070160
GeneOntologyCellularComponent	chromatin	NELFE ANKRD31 SP1 ING3 ATRX STAG1 ZMYND8 ICE1 POGZ MED1 RFX7 ARID1A HOXA3 NFX1 AHR TSHZ1 AFF4	7.83e-04	1480	102	17	GO:0000785
GeneOntologyCellularComponent	cyclin/CDK positive transcription elongation factor complex	CCNT2 CDK13	8.30e-04	9	102	2	GO:0008024
GeneOntologyCellularComponent	apical junction complex	SH3BP1 MPDZ NPHP4 FRMD4A CGNL1	1.07e-03	158	102	5	GO:0043296
HumanPheno	Thin upper lip vermilion	MCPH1 ATRX TNRC6B POGZ SPECC1L HUWE1 RFX7 ARID1A CDK13 MYO18B CNOT2 AFF4	1.29e-06	339	35	12	HP:0000219
HumanPheno	Thin lips	MCPH1 ATRX TNRC6B POGZ SPECC1L HUWE1 RFX7 ARID1A CDK13 MYO18B CNOT2 AFF4	1.29e-06	339	35	12	HP:0000213
HumanPheno	Thin vermilion border	MCPH1 ATRX TNRC6B POGZ SPECC1L HUWE1 RFX7 ARID1A CDK13 MYO18B CNOT2 AFF4	1.67e-05	433	35	12	HP:0000233
HumanPheno	Abnormality of upper lip vermillion	MCPH1 ATRX TNRC6B POGZ SPECC1L HUWE1 RFX7 ARID1A CDK13 MYO18B CNOT2 AFF4	3.36e-05	464	35	12	HP:0011339
Domain	R3H	ARPP21 NFX1 R3HDM1	1.22e-05	9	100	3	SM00393
Domain	R3H	ARPP21 NFX1 R3HDM1	2.38e-05	11	100	3	PS51061
Domain	R3H	ARPP21 NFX1 R3HDM1	2.38e-05	11	100	3	PF01424
Domain	-	ARPP21 NFX1 R3HDM1	2.38e-05	11	100	3	3.30.1370.50
Domain	R3H_dom	ARPP21 NFX1 R3HDM1	2.38e-05	11	100	3	IPR001374
Domain	SUZ	ARPP21 R3HDM1	8.48e-05	3	100	2	PF12752
Domain	SUZ	ARPP21 R3HDM1	1.69e-04	4	100	2	IPR024771
Domain	TF_AF4/FMR2	AFF1 AFF4	1.69e-04	4	100	2	IPR007797
Domain	SUZ	ARPP21 R3HDM1	1.69e-04	4	100	2	PS51673
Domain	AF-4	AFF1 AFF4	1.69e-04	4	100	2	PF05110
Domain	Znf_C2H2_jaz	DNAJC21 ZNF638 ZFR	2.13e-04	22	100	3	IPR022755
Domain	zf-C2H2_jaz	DNAJC21 ZNF638 ZFR	2.13e-04	22	100	3	PF12171
Domain	Zinc_finger_PHD-type_CS	ING3 INTS12 ZMYND8 NFX1	4.08e-04	65	100	4	IPR019786
Domain	ZnF_U1	DNAJC21 ZNF638 ZFR	4.92e-04	29	100	3	SM00451
Domain	Znf_U1	DNAJC21 ZNF638 ZFR	4.92e-04	29	100	3	IPR003604
Domain	Znf_PHD-finger	ING3 INTS12 ZMYND8 NFX1	8.55e-04	79	100	4	IPR019787
Domain	SH3_2	RIMBP3 RIMBP3C RIMBP3B FYB1	1.17e-03	86	100	4	IPR011511
Domain	SH3_2	RIMBP3 RIMBP3C RIMBP3B FYB1	1.17e-03	86	100	4	PF07653
Domain	ZF_PHD_2	ING3 INTS12 ATRX ZMYND8	1.70e-03	95	100	4	PS50016
Domain	ZF_PHD_1	ING3 INTS12 ATRX ZMYND8	1.76e-03	96	100	4	PS01359
Domain	ARM-like	SETX STAG1 CLASP1 HUWE1 ARID1A HECTD1	3.31e-03	270	100	6	IPR011989
Domain	FN3	MYOM1 RIMBP3 LRFN5 RIMBP3C RIMBP3B	4.34e-03	199	100	5	PS50853
Domain	FN3_dom	MYOM1 RIMBP3 LRFN5 RIMBP3C RIMBP3B	5.33e-03	209	100	5	IPR003961
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	PCNP UIMC1 SETX ING3 INTS12 ATRX CLASP1 ZMYND8 DNAJC21 TNRC6B MPDZ ICE1 SPECC1L MED1 SRFBP1 GREB1L CRACD FARSA CDK13 SAP30BP NFX1 RBM15B CNOT2 AFF4	7.38e-12	1497	102	24	31527615
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	UIMC1 TTF2 ZNF609 STAG1 CLASP1 ZMYND8 DNAJC21 TNRC6B MED1 ANKRD50 ARID1A ASAP1 RTF1 C1orf198 ARHGAP21	9.28e-12	472	102	15	38943005
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	UIMC1 TTF2 SP1 ZNF609 SETX ATXN7L2 ING3 INTS12 MCPH1 ATRX ZMYND8 POGZ MED1 RFX7 ARID1A SRFBP1 CDK13 ZNF644 SAP30BP RBM15B ZNF638 ZFR	2.09e-11	1294	102	22	30804502
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	NELFE PCNP UIMC1 TTF2 ATRX RPAP3 ZMYND8 TNRC6B ICE1 MED1 CRACD UBE2O KIAA1217 SAP30BP ZNF638 ZFR CGNL1 ARHGAP21 AFF4	2.91e-11	934	102	19	33916271
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	MAGEB2 ZNF609 CLASP1 RPAP3 TNRC6B MPDZ FASTKD5 ICE1 HUWE1 CEP350 FARSA UBE2O ZNF638 TMEM131 R3HDM1 HECTD1 CNOT2	4.82e-11	733	102	17	34672954
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	IQSEC3 CLASP1 TNRC6B POGZ ASAP1 GRAMD1B CRACD ZNF644 MARK4 COBL R3HDM1 ARHGAP21 WDR48	2.33e-10	407	102	13	12693553
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	NELFE UIMC1 ZNF609 SETX ATRX ZMYND8 ICE1 POGZ MED1 ARID1A SRFBP1 SRSF12 ZNF644 SAP30BP RBM15B ZNF638 ZFR AFF4	3.43e-10	954	102	18	36373674
Pubmed	HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137.	NELFE PCNP ATRX ZMYND8 CCNT2 SAP30BP ZNF638 ZFR AFF4	5.86e-10	148	102	9	32538781
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	NELFE PCNP ATRX ZMYND8 MED1 SRFBP1 RTF1 SAP30BP ZNF638 ZFR AFF4	7.89e-10	283	102	11	30585729
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	NELFE PCNP TTF2 RPAP3 TNRC6B MPDZ POGZ SPECC1L HUWE1 MED1 ARID1A UBE2O SAP30BP ZFR	8.44e-10	549	102	14	38280479
Pubmed	Human transcription factor protein interaction networks.	UIMC1 SP1 ZNF609 ATXN7L2 ING3 INTS12 ATRX KRT74 ZMYND8 HIPK2 TNRC6B POGZ RFX7 ARID1A UBE2O ZNF644 ZNF638 ZFR R3HDM1 CNOT2 WDR48	9.00e-10	1429	102	21	35140242
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	NELFE UIMC1 SP1 ATRX CLASP1 ZMYND8 POGZ HUWE1 MED1 RFX7 CCNT2 CDK13 ZNF644 RBM15B ZNF638 AFF1	9.95e-10	774	102	16	15302935
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	UIMC1 SETX INTS12 ATRX CLASP1 CAMK2B HIPK2 HUWE1 ARID1A RIMBP3 FARSA ZNF644 KIAA1217 CGNL1	2.03e-09	588	102	14	38580884
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	IQSEC3 CLASP1 CAMK2B SH3BP1 TNRC6B MPDZ SPECC1L HUWE1 ADAM22 FARSA UBE2O ZC2HC1A KIAA1217 ZFR EML1 ARHGAP21 AFF4	3.04e-09	963	102	17	28671696
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	NELFE PCNP ZNF609 RPAP3 DNAJC21 TNRC6B POGZ SPECC1L MED1 CEP350 NFX1 ZFR TMEM131 R3HDM1 WDR48	3.38e-09	724	102	15	36232890
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	NELFE SETX INTS12 CLASP1 PARP8 MPDZ RFX7 LYST CEP350 KIAA1217 MARK4 COBL CGNL1 R3HDM1 HECTD1 ARHGAP21	4.52e-09	861	102	16	36931259
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	NELFE PCNP STAG1 ZMYND8 POGZ MED1 ARID1A ZNF644 ZNF638 CNOT2 AFF4	5.52e-09	341	102	11	32971831
Pubmed	The protein interaction landscape of the human CMGC kinase group.	NELFE SEMG2 FASTKD5 ICE1 HUWE1 MED1 SRSF12 RTF1 CEP350 CCNT2 CDK13 AFF1 CNOT2 AFF4	1.68e-08	695	102	14	23602568
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	TTF2 RPAP3 TNRC6B IFT46 ASAP1 CEP350 RIMBP3 C1orf198 ZC2HC1A KIAA1217 NFX1 COBL TMEM131 CGNL1 ARHGAP21	2.98e-08	853	102	15	28718761
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	NELFE SP1 ZNF609 ING3 ATRX MCM8 FASTKD5 MED1 RTF1 CCNT2 CRACD CDK13 FRZB AHR R3HDM1 HECTD1 CNOT2 WDR48	5.69e-08	1327	102	18	32694731
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	TTF2 MCM8 CLASP1 RPAP3 POGZ SNX16 ANKRD50 CEP350 C1orf198 ZC2HC1A KIAA1217 NFX1 AHR R3HDM1 ARHGAP21 CNOT2	6.06e-08	1038	102	16	26673895
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	TNRC6B ARID1A UBE2O KIAA1217 NFX1 ZNF638 TMEM131 R3HDM1 ARHGAP21	8.75e-08	263	102	9	34702444
Pubmed	RIM-BP3 is a manchette-associated protein essential for spermiogenesis.	RIMBP3 RIMBP3C RIMBP3B	9.78e-08	4	102	3	19091768
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	UIMC1 ZNF609 SETX MCPH1 STAG1 ICE1 SPECC1L MED1 ARID1A FARSA ZFR	9.98e-08	453	102	11	29656893
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	CLASP1 TNRC6B MPDZ CEP350 UBE2O COBL HECTD1 ARHGAP21	2.01e-07	209	102	8	36779422
Pubmed	Structure and evolution of RIM-BP genes: identification of a novel family member.	RIMBP3 RIMBP3C RIMBP3B	2.44e-07	5	102	3	17855024
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	ATRX CLASP1 CAMK2B HIPK2 FASTKD5 LYST RTF1 GRAMD1B CCNT2 CDK13 SAP30BP AFF1 ARHGAP21 AFF4	4.50e-07	910	102	14	36736316
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	ZNF609 RPAP3 ZMYND8 TNRC6B ICE1 POGZ HUWE1 GREB1L ZNF644 ARHGAP21	4.50e-07	418	102	10	34709266
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	ZNF609 SETX ATRX MCM8 RPAP3 DNAJC21 MPDZ ANKRD50 CDK13 ZNF638 ARHGAP21 WDR48	4.80e-07	650	102	12	38777146
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	NELFE PCNP SETX CLASP1 TNRC6B POGZ SPECC1L MED1 SRFBP1 CEP350 FARSA CDK13 SAP30BP NFX1 RBM15B AHR AFF4	4.90e-07	1371	102	17	36244648
Pubmed	Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	ANKRD50 ASAP1 GRAMD1B CRACD ZNF644 KIAA1217	6.23e-07	103	102	6	10574462
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	ZNF609 DNAJC21 TNRC6B SPECC1L HUWE1 MED1 RFX7 ARID1A CCNT2 FARSA ZC2HC1A AHR AFF1 HECTD1 CNOT2 AFF4	7.08e-07	1247	102	16	27684187
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	SP1 ZNF609 ING3 INTS12 ZMYND8 POGZ ARID1A ZC2HC1A ZNF644 AHR ZNF638 ZFR CNOT2	7.29e-07	808	102	13	20412781
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	NELFE PCNP TTF2 ZNF609 SETX INTS12 CLASP1 ZMYND8 POGZ MED1 ARID1A CCNT2 CDK13 ZNF644 ZFR	7.96e-07	1103	102	15	34189442
Pubmed	Overlapping Activities of Two Neuronal Splicing Factors Switch the GABA Effect from Excitatory to Inhibitory by Regulating REST.	CLASP1 CAMK2B ADAM22 GRAMD1B R3HDM1 ARHGAP21	2.23e-06	128	102	6	30995482
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	NELFE ING3 MED1 ARID1A RTF1 CRACD UBE2O CDK13 SAP30BP ZFR	2.51e-06	506	102	10	30890647
Pubmed	Human mediator subunit MED26 functions as a docking site for transcription elongation factors.	ICE1 MED1 CCNT2 AFF1 AFF4	2.52e-06	73	102	5	21729782
Pubmed	BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.	NELFE ATXN7L2 ING3 ZMYND8 MED1 ARID1A	2.91e-06	134	102	6	25452129
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	PCNP SETX ATRX HIPK2 HUWE1 ANKRD50 ASAP1 NFX1 ZNF638 AFF1 TMEM131 ARHGAP21 CNOT2 AFF4	3.49e-06	1084	102	14	11544199
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	IQSEC3 CLASP1 CAMK2B SPECC1L ARID1A ADAM22 ASAP1 GRAMD1B CRACD FARSA UBE2O ZC2HC1A KIAA1217 SCN2A CGNL1 ARHGAP21	4.18e-06	1431	102	16	37142655
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ZNF609 ATXN7L2 ING3 MCM8 ZMYND8 TNRC6B FASTKD5 POGZ ARID1A MARK4 SAP30BP AHR AFF4 WDR48	4.87e-06	1116	102	14	31753913
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	SP1 ZNF609 ING3 ZMYND8 ASAP1 SAP30BP AFF1 ZFR TSHZ1	5.16e-06	430	102	9	35044719
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ATRX STAG1 ZMYND8 POGZ HUWE1 ARID1A ADAM22 CEP350 UBE2O TMEM131 R3HDM1 HECTD1 ARHGAP21 CNOT2 AFF4	5.16e-06	1285	102	15	35914814
Pubmed	A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition.	SEMG2 ATRX HUWE1 RFX7 SRFBP1 UBE2O C1orf198 MARK4 AFF1	5.25e-06	431	102	9	33660365
Pubmed	The little elongation complex regulates small nuclear RNA transcription.	ICE1 AFF1 AFF4	5.29e-06	12	102	3	22195968
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: I. The complete nucleotide sequences of 100 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ZMYND8 SPECC1L HUWE1 FRMD4A TMEM131	6.00e-06	87	102	5	12465718
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	NELFE PCNP UIMC1 ZNF609 SETX RPAP3 TNRC6B MED1 C1orf198	6.67e-06	444	102	9	34795231
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ZNF609 MCPH1 ATRX MCM8 CAMK2B HIPK2 TNRC6B HUWE1 ARID1A CDK13 KIAA1217 ZNF638 COBL AFF1 HECTD1 AFF4	6.90e-06	1489	102	16	28611215
Pubmed	Analysis of Ku70 S155 Phospho-Specific BioID2 Interactome Identifies Ku Association with TRIP12 in Response to DNA Damage.	INTS12 RPAP3 MED1 RTF1 SAP30BP ZNF638	6.98e-06	156	102	6	37108203
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	TTF2 SETX ING3 INTS12 STAG1 ZMYND8 POGZ HUWE1 CRACD ZNF644 ZFR TSHZ1	8.24e-06	857	102	12	25609649
Pubmed	Distinct roles of two SEC scaffold proteins, AFF1 and AFF4, in regulating RNA polymerase II transcription elongation.	AFF1 AFF4	8.52e-06	2	102	2	37528066
Pubmed	Overexpression of antioxidant enzymes upregulates aryl hydrocarbon receptor expression via increased Sp1 DNA-binding activity.	SP1 AHR	8.52e-06	2	102	2	20478378
Pubmed	AFF4 binding to Tat-P-TEFb indirectly stimulates TAR recognition of super elongation complexes at the HIV promoter.	AFF1 AFF4	8.52e-06	2	102	2	24843025
Pubmed	AHR promoter variant modulates its transcription and downstream effectors by allele-specific AHR-SP1 interaction functioning as a genetic marker for vitiligo.	SP1 AHR	8.52e-06	2	102	2	26370050
Pubmed	Gene target specificity of the Super Elongation Complex (SEC) family: how HIV-1 Tat employs selected SEC members to activate viral transcription.	AFF1 AFF4	8.52e-06	2	102	2	26007649
Pubmed	Integrative characterization of germ cell-specific genes from mouse spermatocyte UniGene library.	RIMBP3 RIMBP3C RIMBP3B	8.71e-06	14	102	3	17662146
Pubmed	MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia.	CCNT2 AFF1 AFF4	8.71e-06	14	102	3	20854876
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	PCNP POGZ SRSF12 SAP30BP RBM15B ZNF638 ZFR	9.67e-06	251	102	7	31076518
Pubmed	Genome-wide CRISPR screens using isogenic cells reveal vulnerabilities conferred by loss of tumor suppressors.	PCNP UIMC1 FASTKD5 ARID1A TGOLN2 AHR ZNF638 HECTD1	1.12e-05	359	102	8	35559673
Pubmed	Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation.	UIMC1 RPAP3 SPECC1L NPHP4 KIAA1217 ZNF638 TMEM131 ARHGAP21	1.17e-05	361	102	8	30344098
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	UIMC1 SETX INTS12 ATRX STAG1 POGZ MED1 UBE2O ZNF644 AFF4	1.25e-05	608	102	10	36089195
Pubmed	A human MAP kinase interactome.	SP1 SETX HIPK2 POGZ SPECC1L ASAP1 CEP350 COBL CGNL1	1.37e-05	486	102	9	20936779
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	NELFE ZNF609 INTS12 ZMYND8 MED1 ARID1A AFF4	1.48e-05	268	102	7	33640491
Pubmed	mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.	MPDZ SPECC1L NFX1 COBL ZFR R3HDM1 ARHGAP21	1.70e-05	274	102	7	34244482
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	SETX CLASP1 ZMYND8 TNRC6B POGZ MED1 ARID1A CCNT2 FARSA ZC2HC1A RBM15B ZNF638 AFF4	1.72e-05	1082	102	13	38697112
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	NELFE SP1 SETX HUWE1 MED1 ZC2HC1A CDK13 ZNF638 TMEM131	1.80e-05	503	102	9	16964243
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	UIMC1 INTS12 ATRX STAG1 TTC16 KRT74 CAMK2B PARP8 DNAJC21 ARID1A LYST CDK13 SAP30BP ZFR ARHGAP21	2.01e-05	1442	102	15	35575683
Pubmed	Lost in transcription: molecular mechanisms that control HIV latency.	SP1 AFF1 AFF4	2.29e-05	19	102	3	23518577
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	TTF2 ZNF609 ING3 IFT46 POGZ ARID1A TSHZ1 ZNF518B	2.36e-05	398	102	8	35016035
Pubmed	Interaction of Sp1 and Setd8 promotes vascular smooth muscle cells apoptosis by activating Mark4 in vascular calcification.	SP1 MARK4	2.55e-05	3	102	2	38301049
Pubmed	Regulation of constitutive gene expression through interactions of Sp1 protein with the nuclear aryl hydrocarbon receptor complex.	SP1 AHR	2.55e-05	3	102	2	10471301
Pubmed	The genetic landscape of familial congenital hydrocephalus.	MPDZ EML1	2.55e-05	3	102	2	28556411
Pubmed	The aryl hydrocarbon receptor mediates degradation of estrogen receptor alpha through activation of proteasomes.	SP1 AHR	2.55e-05	3	102	2	12612060
Pubmed	AhR regulates the expression of human cytochrome P450 1A1 (CYP1A1) by recruiting Sp1.	SP1 AHR	2.55e-05	3	102	2	31199573
Pubmed	AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23).	AFF1 AFF4	2.55e-05	3	102	2	10588740
Pubmed	Molecular mechanism of inhibitory aryl hydrocarbon receptor-estrogen receptor/Sp1 cross talk in breast cancer cells.	SP1 AHR	2.55e-05	3	102	2	16675542
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	FASTKD5 SRFBP1 SRSF12 FARSA UBE2O CDK13 NFX1 RBM15B ZNF638 ZFR R3HDM1	2.57e-05	807	102	11	22681889
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	PCNP IQSEC3 CAMK2B TNRC6B HUWE1 ADAM22 ASAP1 GRAMD1B FRMD4A UBE2O C1orf198 KIAA1217 CNOT2	2.93e-05	1139	102	13	36417873
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	NELFE UIMC1 ATXN7L2 MPDZ ICE1 HUWE1 FARSA UBE2O MARK4 ZFR HECTD1 WDR48	3.94e-05	1005	102	12	19615732
Pubmed	ATG5 is required for B cell polarization and presentation of particulate antigens.	NELFE PCNP SP1 SPECC1L MED1 FARSA SAP30BP RBM15B ZNF638 WDR48	4.18e-05	701	102	10	30196744
Pubmed	KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4.	NELFE SRFBP1 RTF1 ZNF638 ZFR	4.21e-05	130	102	5	35545047
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	SP1 ING3 ZMYND8 POGZ ARID1A NFX1 AHR ZNF638 ZFR CNOT2	4.60e-05	709	102	10	22988430
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	ZNF609 ATRX ZMYND8 HIPK2 ARID1A ZFR	4.86e-05	220	102	6	35785414
Pubmed	Importance of a specific amino acid pairing for murine MLL leukemias driven by MLLT1/3 or AFF1/4.	AFF1 AFF4	5.09e-05	4	102	2	25282333
Pubmed	SynGAP-MUPP1-CaMKII synaptic complexes regulate p38 MAP kinase activity and NMDA receptor-dependent synaptic AMPA receptor potentiation.	CAMK2B MPDZ	5.09e-05	4	102	2	15312654
Pubmed	A Minor Subset of Super Elongation Complexes Plays a Predominant Role in Reversing HIV-1 Latency.	AFF1 AFF4	5.09e-05	4	102	2	26830226
Pubmed	Functional and physical interactions between the estrogen receptor Sp1 and nuclear aryl hydrocarbon receptor complexes.	SP1 AHR	5.09e-05	4	102	2	9611253
Pubmed	Impaired conditioned fear and enhanced long-term potentiation in Fmr2 knock-out mice.	AFF1 AFF4	5.09e-05	4	102	2	11923441
Pubmed	Mediation of Af4 protein function in the cerebellum by Siah proteins.	AFF1 AFF4	5.09e-05	4	102	2	15459319
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	ING3 ATRX POGZ ZNF644 ZNF518B AFF4	5.11e-05	222	102	6	37071664
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	TTF2 CLASP1 PARP8 TNRC6B MPDZ ARID1A R3HDM1 HECTD1	5.26e-05	446	102	8	24255178
Pubmed	A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal.	ZNF609 POGZ ARID1A KIAA1217 ZFR	7.31e-05	146	102	5	23892456
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	PCNP SETX ATRX HUWE1 ARID1A CDK13 SAP30BP ZNF638	7.47e-05	469	102	8	27634302
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	SH3BP1 MPDZ HUWE1 SRFBP1 ASAP1 CCNT2 FARSA COBL ZFR PLG ARHGAP21	8.02e-05	916	102	11	32203420
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	ATRX STAG1 SH3BP1 TNRC6B MPDZ NFX1 ZFR PLG	8.16e-05	475	102	8	31040226
Pubmed	ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair.	UIMC1 ING3 ZMYND8 POGZ ARID1A	8.30e-05	150	102	5	28242625
Pubmed	Aberrant calcium/calmodulin-dependent protein kinase II (CaMKII) activity is associated with abnormal dendritic spine morphology in the ATRX mutant mouse brain.	ATRX CAMK2B	8.47e-05	5	102	2	21209221
Pubmed	Activity-Based Probes for HECT E3 Ubiquitin Ligases.	HUWE1 HECTD1	8.47e-05	5	102	2	28425671
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	SETX TNRC6B SPECC1L HUWE1 ANKRD50 CEP350 ZNF638 ZFR CGNL1 ARHGAP21	9.80e-05	777	102	10	35844135
Pubmed	TRIM65 regulates microRNA activity by ubiquitination of TNRC6.	DNAJC21 TNRC6B UBE2O ZNF638 ZFR HECTD1 CNOT2	1.02e-04	364	102	7	24778252
Interaction	TERF2IP interactions	NELFE PCNP UIMC1 ZNF609 SETX ARPP21 ZMYND8 POGZ MED1 ARID1A RTF1 CDK13 ZNF644 SAP30BP AHR ZNF638 HECTD1 AFF4	2.19e-10	552	100	18	int:TERF2IP
Interaction	YWHAH interactions	NELFE SETX INTS12 CLASP1 PARP8 MPDZ SPECC1L HUWE1 MED1 RFX7 LYST SRSF12 CEP350 FRMD4A KIAA1217 MARK4 RBM15B ZNF638 COBL CGNL1 R3HDM1 HECTD1 ARHGAP21	3.25e-09	1102	100	23	int:YWHAH
Interaction	MYCN interactions	PCNP SP1 MAGEB2 ZNF609 MCM8 STAG1 ZMYND8 DNAJC21 TNRC6B POGZ HUWE1 ARID1A SRFBP1 LYST SRSF12 ZC2HC1A CDK13 SAP30BP NFX1 RBM15B ZNF638 ZFR PLG R3HDM1	4.28e-08	1373	100	24	int:MYCN
Interaction	YWHAG interactions	NELFE CLASP1 RPAP3 PARP8 MPDZ SPECC1L HUWE1 RFX7 LYST TGOLN2 SRSF12 CEP350 CRACD FRMD4A MARK4 RBM15B ZNF638 COBL CGNL1 R3HDM1 HECTD1 ARHGAP21	1.53e-07	1248	100	22	int:YWHAG
Interaction	NAA40 interactions	NELFE PCNP UIMC1 TTF2 ATRX RPAP3 ZMYND8 TNRC6B ICE1 MED1 CRACD UBE2O KIAA1217 SAP30BP ZNF638 ZFR CGNL1 ARHGAP21 AFF4	2.88e-07	978	100	19	int:NAA40
Interaction	PPIA interactions	NELFE UIMC1 TTF2 ZNF609 STAG1 CLASP1 ZMYND8 DNAJC21 TNRC6B HUWE1 MED1 ANKRD50 ARID1A LYST ASAP1 RTF1 C1orf198 ARHGAP21	3.35e-07	888	100	18	int:PPIA
Interaction	SMC5 interactions	NELFE UIMC1 ZNF609 SETX ATRX ZMYND8 ICE1 POGZ MED1 ARID1A SRFBP1 SRSF12 ZNF644 SAP30BP RBM15B ZNF638 ZFR HECTD1 AFF4	4.05e-07	1000	100	19	int:SMC5
Interaction	XRCC6 interactions	NELFE PCNP INTS12 ATRX RPAP3 ZMYND8 ICE1 HUWE1 MED1 SRFBP1 RTF1 UBE2O SAP30BP NFX1 ZNF638 ZFR HECTD1 AFF4	6.36e-07	928	100	18	int:XRCC6
Interaction	DCTN1 interactions	TTF2 CLASP1 DNAJC21 SPECC1L HUWE1 CEP350 UBE2O ZC2HC1A KIAA1217 SAP30BP EML1 HECTD1 ARHGAP21	1.07e-06	497	100	13	int:DCTN1
Interaction	H2BC21 interactions	NELFE UIMC1 ATRX ZMYND8 HIPK2 DNAJC21 POGZ HUWE1 ARID1A RTF1 ZNF644 ZNF638 ZNF518B FYB1 WDR48	1.70e-06	696	100	15	int:H2BC21
Interaction	MAPRE3 interactions	TTF2 CLASP1 SPECC1L CEP350 ZC2HC1A KIAA1217 COBL TMEM131 ARHGAP21	2.17e-06	230	100	9	int:MAPRE3
Interaction	CBX3 interactions	NELFE UIMC1 ATXN7L2 ATRX ZMYND8 HIPK2 POGZ MED1 SRFBP1 TGOLN2 RTF1 UBE2O ZNF644 ZNF518B	3.65e-06	646	100	14	int:CBX3
Interaction	PNMA2 interactions	SETX CAMK2B NPHP4 CEP350 ZNF644 MARK4 RIMBP3C ARHGAP21 WDR48	4.43e-06	251	100	9	int:PNMA2
Interaction	POLR1G interactions	MAGEB2 RPAP3 ZMYND8 FASTKD5 ICE1 POGZ HUWE1 SRFBP1 RTF1 ZNF644 HECTD1 AFF4	5.52e-06	489	100	12	int:POLR1G
Interaction	SSRP1 interactions	NELFE SETX INTS12 ATRX ZMYND8 HUWE1 ARID1A SRFBP1 RTF1 UBE2O ZNF644 ZNF638 ZFR HECTD1	7.14e-06	685	100	14	int:SSRP1
Interaction	ELL3 interactions	ICE1 CCNT2 AFF1 AFF4	7.85e-06	26	100	4	int:ELL3
Interaction	YWHAB interactions	NELFE CLASP1 RPAP3 CAMK2B PARP8 RFX7 LYST ADAM22 TGOLN2 SRSF12 CEP350 MARK4 ZNF638 CGNL1 R3HDM1 HECTD1 ARHGAP21	9.53e-06	1014	100	17	int:YWHAB
Interaction	YWHAE interactions	NELFE CLASP1 RPAP3 PARP8 HUWE1 LYST TGOLN2 CRACD FRMD4A UBE2O CDK13 MARK4 NFX1 ZNF638 CGNL1 R3HDM1 HECTD1 ARHGAP21 WDR48	1.15e-05	1256	100	19	int:YWHAE
Interaction	SKAP1 interactions	TTF2 SETX MCM8 NPHP4 ZNF644 FYB1	1.18e-05	102	100	6	int:SKAP1
Interaction	NIN interactions	TTF2 CLASP1 TNRC6B IFT46 CEP350 C1orf198 KIAA1217 CGNL1 HECTD1 ARHGAP21	1.19e-05	359	100	10	int:NIN
Interaction	FMR1 interactions	CLASP1 CAMK2B ZMYND8 TNRC6B ZC2HC1A KIAA1217 ZFR EML1 R3HDM1 HECTD1 ARHGAP21 AFF4	1.39e-05	536	100	12	int:FMR1
Interaction	NINL interactions	TTF2 CAMK2B TNRC6B HUWE1 CEP350 C1orf198 KIAA1217 COBL TMEM131 CGNL1 ARHGAP21	1.70e-05	458	100	11	int:NINL
Interaction	CDK12 interactions	MAGEB2 ATRX MED1 ANKRD50 NPHP4 CDK13 HECTD1 AFF4	1.81e-05	228	100	8	int:CDK12
Interaction	GSK3A interactions	CLASP1 TTC16 PARP8 TNRC6B MPDZ RFX7 CEP350 UBE2O COBL HECTD1 ARHGAP21	1.92e-05	464	100	11	int:GSK3A
Interaction	ELL2 interactions	ICE1 CCNT2 AFF1 AFF4	2.09e-05	33	100	4	int:ELL2
Interaction	FHL2 interactions	SP1 ING3 HIPK2 POGZ KIAA1217 SAP30BP AHR ZNF638 ZFR CNOT2	2.75e-05	396	100	10	int:FHL2
Interaction	AR interactions	NELFE SP1 ZNF609 INTS12 ATRX ZMYND8 HIPK2 HUWE1 MED1 ARID1A FARSA KIAA1217 AHR ZFR AFF4 WDR48	2.89e-05	992	100	16	int:AR
Interaction	DLGAP1 interactions	IQSEC3 CAMK2B MPDZ HUWE1 ADAM22 UBE2O KIAA1217	3.21e-05	180	100	7	int:DLGAP1
Interaction	SS18L2 interactions	IFT46 ARID1A UBE2O AHR CNOT2	3.80e-05	76	100	5	int:SS18L2
Interaction	ZYX interactions	HIPK2 TNRC6B CEP350 CRACD C1orf198 KIAA1217 COBL ZFR ARHGAP21	3.82e-05	329	100	9	int:ZYX
Interaction	ACTC1 interactions	NELFE SP1 ING3 MED1 ARID1A NPHP4 RTF1 CRACD UBE2O CDK13 SAP30BP COBL ZFR	3.87e-05	694	100	13	int:ACTC1
Interaction	FOXJ2 interactions	INTS12 ZMYND8 POGZ ZNF644 TSHZ1	5.17e-05	81	100	5	int:FOXJ2
Interaction	RNF43 interactions	DNAJC21 TNRC6B ARID1A UBE2O KIAA1217 NFX1 ZNF638 TMEM131 R3HDM1 ARHGAP21	5.20e-05	427	100	10	int:RNF43
Interaction	TERF1 interactions	ARPP21 STAG1 RPAP3 SH3BP1 HOXA3 CDK13 SAP30BP RBM15B HECTD1	5.76e-05	347	100	9	int:TERF1
Interaction	HAPSTR1 interactions	SEMG2 INTS12 ATRX MPDZ HUWE1 RFX7 ARID1A SRFBP1 UBE2O C1orf198 MARK4 AFF1 HECTD1 WDR48	5.89e-05	829	100	14	int:HAPSTR1
Interaction	TFPI2 interactions	IFT46 TGOLN2 UBE2O PLG	6.07e-05	43	100	4	int:TFPI2
Interaction	HNF4A interactions	SP1 ZNF609 ING3 ATRX POGZ MED1 ARID1A ZNF644	6.83e-05	275	100	8	int:HNF4A
Interaction	MYCBP2 interactions	IQSEC3 CLASP1 CAMK2B SPECC1L HUWE1 TGOLN2 HECTD1 ARHGAP21 WDR48	6.86e-05	355	100	9	int:MYCBP2
Interaction	PARP1 interactions	UIMC1 SP1 STAG1 CAMK2B HIPK2 POGZ HUWE1 MED1 SRFBP1 RTF1 UBE2O CDK13 ZNF644 NFX1 AHR CGNL1 HECTD1 AFF4	7.57e-05	1316	100	18	int:PARP1
Interaction	YWHAZ interactions	NELFE CLASP1 CAMK2B PARP8 HUWE1 ARID1A LYST ADAM22 GRAMD1B CRACD ZNF644 MARK4 NFX1 ZNF638 CGNL1 R3HDM1 HECTD1 ARHGAP21	7.80e-05	1319	100	18	int:YWHAZ
Interaction	TRIM36 interactions	CLASP1 SPECC1L CEP350 ZC2HC1A NFX1 ARHGAP21	8.23e-05	144	100	6	int:TRIM36
Interaction	NXF1 interactions	PCNP UIMC1 SP1 ATXN7L2 TNRC6B MPDZ POGZ ARID1A ADAM22 GREB1L CEP350 UBE2O ZNF644 SAP30BP NFX1 RBM15B ZFR HECTD1	1.00e-04	1345	100	18	int:NXF1
Interaction	YWHAQ interactions	NELFE CLASP1 PARP8 SPECC1L MED1 RFX7 LYST SRSF12 CEP350 NFX1 ZNF638 CGNL1 PLG R3HDM1 HECTD1 ARHGAP21	1.19e-04	1118	100	16	int:YWHAQ
Interaction	CCNT1 interactions	MED1 CCNT2 RBM15B AHR AFF1 ARHGAP21 AFF4	1.31e-04	225	100	7	int:CCNT1
Interaction	RUVBL1 interactions	NELFE ING3 RPAP3 HUWE1 ARID1A TGOLN2 RTF1 UBE2O NFX1 PLG HECTD1	1.32e-04	575	100	11	int:RUVBL1
Interaction	EXOSC9 interactions	SETX STAG1 PARP8 RTF1 NFX1 HECTD1	1.57e-04	162	100	6	int:EXOSC9
Interaction	MEN1 interactions	NELFE PCNP ZNF609 ATRX STAG1 ZMYND8 POGZ MED1 ARID1A ZNF644 ZNF638 COBL ZFR CNOT2 AFF4	1.63e-04	1029	100	15	int:MEN1
Interaction	ZCCHC17 interactions	MAGEB2 ING3 ZMYND8 UBE2O HECTD1	1.70e-04	104	100	5	int:ZCCHC17
Interaction	DDB1 interactions	ZMYND8 HUWE1 MED1 NPHP4 TGOLN2 UBE2O SAP30BP NFX1 AHR HECTD1 CNOT2 WDR48	1.73e-04	697	100	12	int:DDB1
Interaction	H3C3 interactions	UIMC1 SETX INTS12 ATRX STAG1 POGZ MED1 UBE2O ZNF644 AFF4	1.75e-04	495	100	10	int:H3C3
Interaction	ENO1 interactions	NELFE PCNP ZNF609 MYOM1 MCPH1 MPDZ POGZ SPECC1L HUWE1 C1orf198 ZNF638 PLG	1.83e-04	701	100	12	int:ENO1
Interaction	TUBA1B interactions	SP1 ATRX CLASP1 HUWE1 ITGAD NPHP4 UBE2O ZC2HC1A NFX1 EML1	1.84e-04	498	100	10	int:TUBA1B
Interaction	CEP120 interactions	TTF2 TNRC6B CEP350 ZC2HC1A ARHGAP21	1.85e-04	106	100	5	int:CEP120
Interaction	MECP2 interactions	SP1 SETX ATRX CLASP1 CAMK2B ZMYND8 HIPK2 TNRC6B POGZ MED1 ARID1A CCNT2 FARSA ZC2HC1A RBM15B ZNF638 AFF4	1.87e-04	1287	100	17	int:MECP2
Interaction	MED26 interactions	ICE1 MED1 CCNT2 AFF1 AFF4	1.94e-04	107	100	5	int:MED26
Interaction	SUPT5H interactions	NELFE SETX INTS12 ATRX ICE1 ARID1A RTF1 CCNT2 SAP30BP	1.96e-04	408	100	9	int:SUPT5H
Interaction	CAPZB interactions	UIMC1 SP1 RPAP3 SH3BP1 DNAJC21 TNRC6B SPECC1L HUWE1 ANKRD50 CRACD FARSA UBE2O NFX1 FYB1 CNOT2	2.01e-04	1049	100	15	int:CAPZB
Interaction	GATA1 interactions	SP1 ZNF609 MED1 ARID1A ZNF638 ZFR	2.11e-04	171	100	6	int:GATA1
Interaction	USP7 interactions	PCNP ANKRD31 SP1 MAGEB2 ZNF609 ATRX ZMYND8 HUWE1 HOXA3 UBE2O SCN2A MARK4 SAP30BP ZNF638 ZFR CGNL1 AFF4	2.37e-04	1313	100	17	int:USP7
Interaction	WDR48 interactions	NELFE UIMC1 HUWE1 ARID1A KIAA1217 WDR48	2.54e-04	177	100	6	int:WDR48
Interaction	SLX9 interactions	ING3 ATRX HUWE1 UBE2O NFX1 HECTD1	2.54e-04	177	100	6	int:SLX9
Interaction	POLR2G interactions	NELFE SETX MCPH1 RPAP3 MED1 WDR48	2.70e-04	179	100	6	int:POLR2G
Interaction	CSNK2B interactions	MAGEB2 ING3 ATRX ZMYND8 POGZ LYST UBE2O ZNF644 SAP30BP NFX1 WDR48	2.72e-04	625	100	11	int:CSNK2B
Interaction	NUP43 interactions	ZNF609 SETX CAMK2B ZMYND8 TNRC6B ICE1 POGZ ARID1A RTF1 CCNT2 ZNF644	2.72e-04	625	100	11	int:NUP43
Interaction	KIF2C interactions	SEMG2 CLASP1 NPHP4 TGOLN2 UBE2O HECTD1	3.04e-04	183	100	6	int:KIF2C
Interaction	AFF1 interactions	UBE2O AFF1 ZFR AFF4	3.25e-04	66	100	4	int:AFF1
Interaction	MYH9 interactions	SP1 MYOM1 TTC16 SPECC1L HUWE1 NPHP4 TGOLN2 SCN2A MARK4 NFX1 COBL ARHGAP21	3.55e-04	754	100	12	int:MYH9
Interaction	B3GALT6 interactions	MCPH1 TGOLN2 HECTD1	3.55e-04	28	100	3	int:B3GALT6
Interaction	MLLT1 interactions	ARID1A CCNT2 UBE2O AFF1 AFF4	3.70e-04	123	100	5	int:MLLT1
Interaction	CEBPA interactions	NELFE PCNP TTF2 ZNF609 SETX INTS12 STAG1 CLASP1 ZMYND8 POGZ MED1 ARID1A CCNT2 CDK13 ZNF644 ZFR	4.02e-04	1245	100	16	int:CEBPA
Interaction	CNTRL interactions	TTF2 CLASP1 TNRC6B NPHP4 CEP350 ARHGAP21	4.03e-04	193	100	6	int:CNTRL
Interaction	MYOD1 interactions	SP1 ZNF609 HUWE1 ARID1A UBE2O ZNF644	4.15e-04	194	100	6	int:MYOD1
Interaction	WDR73 interactions	MCPH1 HUWE1 ARID1A	4.37e-04	30	100	3	int:WDR73
Interaction	EAF1 interactions	ATRX ICE1 UBE2O AFF1 AFF4	4.44e-04	128	100	5	int:EAF1
Interaction	POLR2B interactions	NELFE INTS12 RPAP3 ZMYND8 HUWE1 MED1 NPHP4 HECTD1	5.22e-04	371	100	8	int:POLR2B
Interaction	TRIM52 interactions	SETX NPHP4 CEP350 ZNF644 AHR	5.29e-04	133	100	5	int:TRIM52
Interaction	GRAMD1B interactions	ANKRD50 TGOLN2 GRAMD1B TMEM131	5.30e-04	75	100	4	int:GRAMD1B
Interaction	H2BC8 interactions	UIMC1 ING3 ATRX STAG1 ZMYND8 POGZ SRFBP1 RTF1 UBE2O ZNF644	5.80e-04	576	100	10	int:H2BC8
Interaction	DCAF4 interactions	MAGEB2 HIPK2 TNRC6B CEP350 UBE2O ZNF644 R3HDM1 WDR48	5.90e-04	378	100	8	int:DCAF4
GeneFamily	AF4/FMR2 family\|Super elongation complex	AFF1 AFF4	7.37e-05	4	64	2	1145
GeneFamily	PHD finger proteins	ING3 INTS12 ZMYND8 NFX1	2.90e-04	90	64	4	88
GeneFamily	AF4/FMR2 family\|Super elongation complex	AFF1 AFF4	4.37e-04	9	64	2	1280
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	PCNP ZNF609 SETX ATRX PARP8 SH3BP1 TNRC6B ICE1 HUWE1 MED1 RFX7 ARID1A LYST ASAP1 TGOLN2 CEP350 CCNT2 CDK13 ZNF644 AHR ZNF638 ZFR FYB1 CNOT2	1.68e-09	1492	101	24	M40023
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	ATRX STAG1 CLASP1 ZMYND8 SPECC1L CEP350 CDK13 ZNF638 AFF1 TMEM131 R3HDM1 CNOT2	2.47e-07	466	101	12	M13522
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	ATRX CLASP1 ZMYND8 ICE1 POGZ CEP350 AHR ZNF638 AFF1 CNOT2	2.55e-07	300	101	10	M8702
Coexpression	GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP	SETX ING3 TNRC6B LYST SAP30BP FYB1 CNOT2 WDR48	1.06e-06	199	101	8	M4460
Coexpression	GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN	PARP8 LYST ZC2HC1A CDK13 AFF1 TMEM131 R3HDM1	2.60e-06	157	101	7	M7733
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	SETX ATRX STAG1 CLASP1 ZMYND8 SPECC1L MED1 CEP350 CDK13 ZNF638 AFF1 TMEM131 R3HDM1 CNOT2	5.20e-06	856	101	14	M4500
Coexpression	GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDC_DN	DNAJC21 ASAP1 HOXA3 RBM15B ZNF638 FYB1 AFF4	1.27e-05	200	101	7	M3833
Coexpression	FAN_EMBRYONIC_CTX_BIG_GROUPS_EXCITATORY_NEURON	ARPP21 CAMK2B SCN2A R3HDM1	3.26e-05	47	101	4	M39019
Coexpression	GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4_KO_BCELL_DN	INTS12 RPAP3 ICE1 SRFBP1 CCNT2 NFX1	1.11e-04	195	101	6	M9813
Coexpression	GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_DN	SETX CLASP1 DNAJC21 CEP350 CDK13 AFF1	1.11e-04	195	101	6	M7382
Coexpression	GSE1925_3H_VS_24H_IFNG_STIM_MACROPHAGE_DN	SEMG2 HIPK2 TNRC6B SNX16 ASAP1 TNFAIP6	1.17e-04	197	101	6	M6291
Coexpression	TBK1.DF_DN	RPAP3 HIPK2 TNRC6B MPDZ RFX7 ZC2HC1A AFF4	1.23e-04	286	101	7	M2864
Coexpression	GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_DN	STAG1 TNRC6B IFT46 LYST ZC2HC1A FYB1	1.24e-04	199	101	6	M6711
Coexpression	GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP	PARP8 RFX7 S1PR3 CDK13 AHR CNOT2	1.27e-04	200	101	6	M9495
Coexpression	GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN	ING3 MED1 TGOLN2 CEP350 CCNT2 CDK13	1.27e-04	200	101	6	M8032
Coexpression	GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_UP	ATRX ZMYND8 TNRC6B FRMD4A TMEM131 FYB1	1.27e-04	200	101	6	M6352
Coexpression	GSE27786_NKTCELL_VS_MONO_MAC_UP	ZMYND8 HUWE1 LYST GRAMD1B CDK13 TSHZ1	1.27e-04	200	101	6	M4870
Coexpression	GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_6H_UP	ING3 INTS12 MYOM1 POGZ AHR AFF4	1.27e-04	200	101	6	M9942
Coexpression	GABRIELY_MIR21_TARGETS	ATRX TNRC6B MPDZ RFX7 RTF1 HECTD1 ARHGAP21	1.31e-04	289	101	7	M2196
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000	ATRX HIPK2 HUWE1 ASAP1 HOXA3 CEP350 CCNT2 ZNF644 KIAA1217 ZNF518B PDZRN4	1.73e-06	379	100	11	gudmap_developingKidney_e15.5_1000_k3
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	SETX INTS12 MCPH1 ATRX MCM8 CLASP1 HIPK2 DNAJC21 FASTKD5 POGZ ARID1A CEP350 CRACD FRMD4A ZIK1 ZNF644 ZNF518B R3HDM1 ARHGAP21	5.54e-06	1257	100	19	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_MaxArch_2500_K3	SETX INTS12 ATRX MCM8 HIPK2 DNAJC21 ARID1A GREB1L CRACD FRMD4A UBE2O ZIK1 ZNF644 FRZB ZNF638 AFF1 TMEM131 R3HDM1	2.00e-05	1252	100	18	facebase_RNAseq_e10.5_MaxArch_2500_K3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000	ARPP21 ING3 ICE1 HUWE1 RFX7 S1PR3 ZIK1 FRZB ZFR ZNF518B TNFAIP6	2.04e-05	492	100	11	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	SETX INTS12 MCPH1 ATRX MCM8 CLASP1 HIPK2 DNAJC21 FASTKD5 POGZ ARID1A CEP350 CRACD FRMD4A ZIK1 ZNF644 ZNF518B R3HDM1 ARHGAP21	4.45e-05	1459	100	19	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	ZNF609 INTS12 ATRX MCM8 CLASP1 PARP8 HIPK2 DNAJC21 POGZ ARID1A NPHP4 CRACD ZIK1 RBM15B ZFR ZNF518B EML1 ARHGAP21	6.51e-05	1370	100	18	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000	MYOM1 ATRX HUWE1 ANKRD50 S1PR3 CCNT2 ZIK1 LRFN5 SCN2A AHR ZNF638 COBL R3HDM1	6.75e-05	772	100	13	gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	SP1 SETX ATRX STAG1 MED1 SRFBP1 RTF1 CEP350 CRACD ZNF644 TMEM131	5.75e-13	186	102	11	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	ATRX HUWE1 MED1 ANKRD50 ARID1A CEP350 AFF1 HECTD1	1.54e-08	193	102	8	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX STAG1 LYST CEP350 ZNF638 ZFR ARHGAP21	1.68e-07	176	102	7	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	human_hepatoblastoma-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	PARP8 ZMYND8 FRMD4A KIAA1217 CGNL1 EML1 PDZRN4	2.63e-07	188	102	7	b070a0667f1ee9b825b267b6c389b7c42fc436f9
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CAMK2B ADAM22 RTF1 FRMD4A LRFN5 SCN2A R3HDM1	3.73e-07	198	102	7	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_\|World / Primary Cells by Cluster	ARPP21 ATRX CAMK2B ZC2HC1A SCN2A EML1 R3HDM1	3.86e-07	199	102	7	058373b4ac3cec2108cb24265628ff0a50646e33
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	CAMK2B ADAM22 RTF1 FRMD4A LRFN5 SCN2A R3HDM1	3.99e-07	200	102	7	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	TTF2 CLASP1 HUWE1 ITGAD CCNT2 NFX1	4.46e-06	186	102	6	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	ILEUM-inflamed-(3)_MNP-(3)_moDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ZMYND8 HIPK2 TNRC6B FRMD4A AHR HECTD1	4.60e-06	187	102	6	0099def970fbc828756fbf853eca2ce77b8cd342
ToppCell	Hippocampus-Neuronal\|Hippocampus / BrainAtlas - Mouse McCarroll V32	CAMK2B SH3BP1 UBE2O LRFN5 SCN2A ZFR	5.68e-06	194	102	6	8aeb347b3024354c9505f4f0fddf0b843489dc6b
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX HUWE1 FRZB ZFR TSHZ1 AFF4	5.85e-06	195	102	6	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CAMK2B ADAM22 FRMD4A LRFN5 SCN2A R3HDM1	6.02e-06	196	102	6	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CAMK2B ADAM22 FRMD4A LRFN5 SCN2A R3HDM1	6.38e-06	198	102	6	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CAMK2B ADAM22 FRMD4A LRFN5 SCN2A R3HDM1	6.38e-06	198	102	6	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CAMK2B ADAM22 FRMD4A LRFN5 SCN2A R3HDM1	6.38e-06	198	102	6	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CAMK2B ADAM22 FRMD4A LRFN5 SCN2A R3HDM1	6.38e-06	198	102	6	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	Control_saline\|World / Treatment groups by lineage, cell group, cell type	SETX MPDZ ANKRD50 KIAA1217 FRZB AHR	6.57e-06	199	102	6	11c9c1779caceb725ecccf3f23b7d4e6dbd1af64
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	ZNF609 STAG1 CLASP1 TNRC6B RFX7 AFF1	6.57e-06	199	102	6	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	ATRX DNAJC21 TNRC6B RTF1 CEP350 ZNF644	6.57e-06	199	102	6	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	HIPK2 MPDZ POGZ ARID1A ASAP1 TMEM131	6.57e-06	199	102	6	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_systemic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MYOM1 GJC1 S1PR3 SRSF12 HOXA3 FRZB	6.57e-06	199	102	6	78a9b26215874a46a910a4b93a51fcac1a597618
ToppCell	(01)_IL1RL1+-(2)_GFP_FOXI1\|(01)_IL1RL1+ / shred by cell type by condition	ATRX DNAJC21 MED1 RTF1 ZNF644 ZFR	6.57e-06	199	102	6	a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26\|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type.	ARPP21 CAMK2B SCN2A FRZB COBL R3HDM1	6.76e-06	200	102	6	61d7dd0a78942b069c3f5e75044368dc00e6e8e6
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SETX ATRX MPDZ KIAA1217 AHR ZNF518B	6.76e-06	200	102	6	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Macroglial-Polydendrocytes-PDGFRA-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ARPP21 PARP8 LRFN5 KIAA1217 SCN2A PDZRN4	6.76e-06	200	102	6	f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2
ToppCell	Macroglial-Polydendrocytes-PDGFRA--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ARPP21 PARP8 LRFN5 KIAA1217 SCN2A PDZRN4	6.76e-06	200	102	6	cc3409518f8b436ea92deb955e81114b3f410ff7
ToppCell	Macroglial-Polydendrocytes-PDGFRA\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ARPP21 PARP8 LRFN5 KIAA1217 SCN2A PDZRN4	6.76e-06	200	102	6	c24a3099e3d96d8b72f6d05286bb355d661a0377
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SETX ATRX CEP350 CDK13 ZNF644 AFF4	6.76e-06	200	102	6	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Macroglial-Polydendrocytes-PDGFRA---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ARPP21 PARP8 LRFN5 KIAA1217 SCN2A PDZRN4	6.76e-06	200	102	6	4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca
ToppCell	Macroglial-Polydendrocytes-PDGFRA----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ARPP21 PARP8 LRFN5 KIAA1217 SCN2A PDZRN4	6.76e-06	200	102	6	310cd53db1c137f6af74e6ae682221d7ac27310c
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26\|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type.	ARPP21 CAMK2B SCN2A FRZB COBL R3HDM1	6.76e-06	200	102	6	5c7263c862093ad9dbc81d06b16b6f74e8a6b634
ToppCell	Macroglial-Polydendrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	ARPP21 PARP8 LRFN5 KIAA1217 SCN2A PDZRN4	6.76e-06	200	102	6	961858738ce35db8760c8c2e136f8369bc444ccf
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|368C / Donor, Lineage, Cell class and subclass (all cells)	ATXN7L2 TTC16 PARP8 ITGAD FYB1	2.24e-05	147	102	5	3ed5b020ce1f1277917d79ef1f7da53fa474e8db
ToppCell	21-Trachea-Epithelial-Submucosal_gland_basal\|Trachea / Age, Tissue, Lineage and Cell class	CAMK2B FRMD4A FRZB CGNL1 MYO18B	3.27e-05	159	102	5	4f670b57b8d3b090ea2f1aafe15baf93cb7ef146
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L4\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ARPP21 DNAJC21 COBL TSHZ1 R3HDM1	3.68e-05	163	102	5	1e8ab00ecc2d2ba35aa6745c0ed38663e26312e8
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ARPP21 DNAJC21 COBL TSHZ1 R3HDM1	3.68e-05	163	102	5	431221a41d396b09170476179590eaf8a55266d8
ToppCell	normal_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th\|T/NK_cells / Location, Cell class and cell subclass	ASAP1 CEP350 ZIK1 ZNF644 ARHGAP21	4.76e-05	172	102	5	0657c736f3c52d25cf7f652eac005ddcde9232ef
ToppCell	LPS-IL1RA+antiTNF\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TNRC6B KIAA1217 COBL CGNL1 ARHGAP21	5.45e-05	177	102	5	b7fee75de7e96924af488a5baa2334711889ae7c
ToppCell	facs-Heart-RV-18m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IQSEC3 MCM8 GJC1 S1PR3 FRMD4A	5.45e-05	177	102	5	7c3d46ebd7e8726be6871aa9763e281fc0ec6ac8
ToppCell	facs-Heart-RV-18m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IQSEC3 MCM8 GJC1 S1PR3 FRMD4A	5.45e-05	177	102	5	e7b1f3092e6b8d0d580f82648035f5ad12be6961
ToppCell	droplet-Marrow-nan-3m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX LYST ASAP1 CEP350 ZNF638	6.22e-05	182	102	5	f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYOM1 GJC1 ASAP1 CRACD PDZRN4	6.38e-05	183	102	5	667717366cb181b8a04a347e64f0f5a4dfc6ee7f
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SETX ATRX LYST CEP350 ZNF638	6.55e-05	184	102	5	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	Posterior_cortex-Neuronal-Excitatory\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	ARPP21 CAMK2B RTF1 SCN2A R3HDM1	6.55e-05	184	102	5	25ccf08a8a26d7e7827b6357f33a53aaf423577d
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADAM22 GREB1L SCN2A AFF1 MYO18B	6.72e-05	185	102	5	d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08
ToppCell	droplet-Marrow-nan-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX LYST ASAP1 CEP350 ZNF638	6.72e-05	185	102	5	7adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell	droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CLASP1 GREB1L CRACD ZNF518B CGNL1	6.89e-05	186	102	5	c116cc9f41971622264434ebe29d18e719b0ae19
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYOM1 S1PR3 FRMD4A FRZB PDZRN4	6.89e-05	186	102	5	a95744b8649096bd7cfc3591a02841fa411085b3
ToppCell	Control-Endothelial-Endothelial-Alv_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HIPK2 KIAA1217 FRZB EML1 ARHGAP21	7.07e-05	187	102	5	ea9d34bcd3bd1f36745846309ede349773de501a
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYOM1 S1PR3 FRMD4A FRZB PDZRN4	7.43e-05	189	102	5	975e7aa3b862a8b07c2ab8426a14f5cc54998aca
ToppCell	tumor_Lymph_Node_/_Brain-Fibroblasts-Pericytes\|Fibroblasts / Location, Cell class and cell subclass	GJC1 HIPK2 S1PR3 FRZB R3HDM1	7.43e-05	189	102	5	f4865b7db16de15120504147a8016ac522ad242a
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX DNAJC21 CEP350 ZFR R3HDM1	7.81e-05	191	102	5	60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX DNAJC21 CEP350 ZFR R3HDM1	7.81e-05	191	102	5	09db184cb90fe282a14474d7217068c58092c6f8
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX DNAJC21 CEP350 ZFR R3HDM1	7.81e-05	191	102	5	973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCell	droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYOM1 CLASP1 CRACD MYO18B PDZRN4	8.00e-05	192	102	5	0bf99e029a06151092db1e8a0dcb45f4e688e771
ToppCell	droplet-Heart-nan-18m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYOM1 CLASP1 CRACD MYO18B PDZRN4	8.00e-05	192	102	5	d766221acfce30cbf2c60b3ae40f6744968b952c
ToppCell	COVID-19-Heart-CM_1\|Heart / Disease (COVID-19 only), tissue and cell type	MYOM1 GREB1L GRAMD1B COBL MYO18B	8.61e-05	195	102	5	f1ef50331eda8f1239dba6ea970df4eaccf032f1
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	MYOM1 GREB1L GRAMD1B COBL MYO18B	8.61e-05	195	102	5	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ARPP21 CAMK2B LRFN5 SCN2A R3HDM1	8.61e-05	195	102	5	2e1df01bf6e4e98e6cd9fb50926e34c5077b8666
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX HUWE1 FRZB ZFR TSHZ1	8.61e-05	195	102	5	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	CV-Moderate-6\|Moderate / Virus stimulation, Condition and Cluster	ATRX PARP8 HUWE1 CEP350 AFF4	8.61e-05	195	102	5	2b8a72d7e755b9655c7a496000d10ff06e50862b
ToppCell	Bronchial_Biopsy-Mesenchymal-Smooth_muscle\|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X	MYOM1 GJC1 FASTKD5 KIAA1217 FRZB	9.03e-05	197	102	5	98f0184a09563a544f0c2d4df22c9db2fbc95019
ToppCell	Brain_organoid-organoid_Velasco_nature-6_mon-Neuronal-Immature_CPNs\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	ARPP21 CAMK2B ZC2HC1A EML1 CNOT2	9.25e-05	198	102	5	4e598aab92141e7d32ec963291ddeed14a21beba
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	ATRX HIPK2 RTF1 CEP350 ZNF644	9.25e-05	198	102	5	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	(00)_Basal-(2)_GFP_FOXI1\|(00)_Basal / shred by cell type by condition	SETX ATRX RTF1 ZFR FYB1	9.47e-05	199	102	5	19674e1eaeb51e4196d847cb62aa437c852951d3
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	SETX ATRX HIPK2 RTF1 ZFR	9.47e-05	199	102	5	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	SETX ATRX HIPK2 TNRC6B CEP350	9.47e-05	199	102	5	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6\|World / Primary Cells by Cluster	ARPP21 ATRX ZC2HC1A SCN2A R3HDM1	9.47e-05	199	102	5	1b1bccf4293f11048709d15a3c892c0edf3da3d2
ToppCell	Neuron\|World / Primary Cells by Cluster	ARPP21 ATRX ZC2HC1A SCN2A R3HDM1	9.47e-05	199	102	5	1f8104fd92f04690b41d9d07ac08dc59d76bb97d
ToppCell	Neuron-Postmitotic\|World / Primary Cells by Cluster	ARPP21 ATRX ZC2HC1A SCN2A R3HDM1	9.47e-05	199	102	5	1973527f8a7d4c6490d75c0d0ea153688166a08b
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal\|World / Primary Cells by Cluster	ARPP21 ATRX ZC2HC1A SCN2A R3HDM1	9.47e-05	199	102	5	4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYOM1 GJC1 ANKRD50 FRMD4A FRZB	9.69e-05	200	102	5	b5b5a32925f225610fe25a021a742d6397162863
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYOM1 S1PR3 FRMD4A FRZB MYO18B	9.69e-05	200	102	5	9169a9ec8e9ab95d90a64c5a19ac666a5cf82313
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	CAMK2B ANKRD50 CRACD R3HDM1 PDZRN4	9.69e-05	200	102	5	bad32a95b759fad509401b07bc96a56687c2a592
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	SETX MPDZ KIAA1217 AHR ZNF518B	9.69e-05	200	102	5	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Alv_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SETX FRZB AHR ZNF518B EML1	9.69e-05	200	102	5	66f7e8ee63c828f17468e79a4b816346b33e8980
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate\|2m / Sample Type, Dataset, Time_group, and Cell type.	ARPP21 CAMK2B ZFR HECTD1 ARHGAP21	9.69e-05	200	102	5	2a635694844ddabcd98462c5636a6f41a3f08a46
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital\|World / Primary Cells by Cluster	ARPP21 CAMK2B ZC2HC1A EML1 R3HDM1	9.69e-05	200	102	5	6bbe8e1f3e91678f1bfb14945365c1578a59a604
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital-19\|World / Primary Cells by Cluster	ARPP21 CAMK2B ZC2HC1A EML1 R3HDM1	9.69e-05	200	102	5	c831d9e0a7178e3634da45548f91fa9e8dc6557c
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	ZNF609 ING3 RFX7 TGOLN2 CEP350 FARSA ZC2HC1A ZFR WDR48	1.29e-07	189	98	9	1045_DN
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A	SETX ZMYND8 ICE1 ARID1A CEP350 GRAMD1B UBE2O CNOT2	1.12e-06	180	98	8	4541_DN
Drug	Ald1.1-H_000455; Up 200; 10uM; PC3; HT_HG-U133A	ZNF609 TNRC6B MPDZ POGZ ARID1A GREB1L TNFAIP6 FYB1	1.75e-06	191	98	8	7547_UP
Drug	Probucol [23288-49-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A	SP1 PARP8 HIPK2 ARID1A LYST ADAM22 CDK13 R3HDM1	2.29e-06	198	98	8	3223_UP
Drug	Antigens, Polyomavirus Transforming	SP1 SETX ING3 INTS12 POGZ SNX16 ARID1A CEP350 SAP30BP ZFR ZNF518B R3HDM1 CNOT2	5.79e-06	668	98	13	ctd:D000952
Drug	Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A	SETX ING3 ZMYND8 ARID1A CEP350 CCNT2 CNOT2	1.50e-05	184	98	7	2321_DN
Drug	Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A	SETX ATRX HIPK2 MED1 CEP350 NFX1 ZFR	1.78e-05	189	98	7	6649_DN
Drug	Pempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A	HIPK2 MED1 LYST TGOLN2 CEP350 ZFR R3HDM1	1.84e-05	190	98	7	4307_DN
Drug	Memantine Hydrochloride [41100-52-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A	ZNF609 CLASP1 ZMYND8 NPHP4 LYST CDK13 AFF4	2.10e-05	194	98	7	7354_DN
Drug	Ethynylestradiol 3-methyl ether [72-33-3]; Up 200; 12.8uM; MCF7; HT_HG-U133A	ZMYND8 HIPK2 GREB1L NFX1 ZFR R3HDM1 FYB1	2.17e-05	195	98	7	4792_UP
Drug	Luteolin [491-70-3]; Down 200; 14uM; MCF7; HT_HG-U133A	ZNF609 CLASP1 ZMYND8 MPDZ ADAM22 EML1 WDR48	2.17e-05	195	98	7	5004_DN
Drug	Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; MCF7; HT_HG-U133A	ZNF609 ATRX POGZ RFX7 NPHP4 CDK13 ZFR	2.17e-05	195	98	7	1505_DN
Drug	CP-320650-01 [172079-28-6]; Up 200; 10uM; PC3; HT_HG-U133A	ZNF609 SETX ADAM22 GREB1L GRAMD1B R3HDM1 FYB1	2.17e-05	195	98	7	4557_UP
Drug	Tetracycline hydrochloride [64-75-5]; Up 200; 8.4uM; PC3; HT_HG-U133A	SP1 ZNF609 GREB1L FRZB COBL AFF1 AFF4	2.25e-05	196	98	7	5757_UP
Drug	1-phenylbiguanide hydrochloride; Down 200; 10uM; MCF7; HG-U133A	MAGEB2 ZNF609 HIPK2 TNRC6B RTF1 AFF1 TNFAIP6	2.32e-05	197	98	7	22_DN
Drug	Cefepime hydrochloride [123171-59-5]; Up 200; 7.4uM; MCF7; HT_HG-U133A	HIPK2 LYST ADAM22 GREB1L FRMD4A FYB1 PDZRN4	2.32e-05	197	98	7	3581_UP
Drug	Alprostadil [745-65-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A	SP1 ZNF609 TNRC6B CDK13 NFX1 AFF1 AFF4	2.32e-05	197	98	7	7358_DN
Drug	Trimethobenzamide hydrochloride [554-92-7]; Up 200; 9.4uM; PC3; HT_HG-U133A	SP1 CAMK2B ADAM22 FRMD4A FRZB COBL AFF4	2.32e-05	197	98	7	4100_UP
Drug	rofecoxib; Up 200; 10uM; MCF7; HG-U133A	MPDZ RFX7 ARID1A NPHP4 ADAM22 CCNT2 TNFAIP6	2.40e-05	198	98	7	256_UP
Drug	Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; MCF7; HT_HG-U133A	SP1 SNX16 CEP350 CCNT2 NFX1 AHR EML1	2.40e-05	198	98	7	1482_DN
Drug	Fusidic acid sodium salt [751-94-0]; Down 200; 7.4uM; MCF7; HT_HG-U133A	SETX ZMYND8 TNRC6B MED1 NFX1 EML1 AFF4	2.48e-05	199	98	7	5353_DN
Drug	Phenindione [83-12-5]; Down 200; 18uM; HL60; HG-U133A	HIPK2 POGZ MED1 NPHP4 RTF1 ZFR WDR48	2.48e-05	199	98	7	1718_DN
Drug	geldanamycin	SETX ATRX RFX7 CDK13 AHR ZNF638 ZFR HECTD1 AFF4	3.23e-05	371	98	9	ctd:C001277
Drug	Digoxigenin [1672-46-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A	SP1 HIPK2 HUWE1 CCNT2 FRMD4A AFF1	1.30e-04	180	98	6	3397_UP
Drug	0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A	ZNF609 SETX MPDZ CEP350 RBM15B WDR48	1.38e-04	182	98	6	3630_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	ZNF609 ATRX STAG1 ZMYND8 HIPK2 ARID1A	1.38e-04	182	98	6	5802_DN
Drug	tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA	SETX ZMYND8 ARID1A CEP350 ZC2HC1A CNOT2	1.50e-04	185	98	6	1114_DN
Drug	Ellipticine [519-23-3]; Down 200; 16.2uM; MCF7; HT_HG-U133A	SETX ING3 ZMYND8 FASTKD5 SPECC1L CCNT2	1.59e-04	187	98	6	2758_DN
Drug	Kawain [500-64-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A	ZNF609 ZMYND8 POGZ SNX16 MARK4 ZFR	1.74e-04	190	98	6	2299_DN
Drug	Chelidonine monohydrate (+) [476-32-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A	CAMK2B HIPK2 MPDZ MED1 CEP350 AFF1	1.79e-04	191	98	6	6236_UP
Drug	Estriol [50-27-1]; Down 200; 13.8uM; MCF7; HT_HG-U133A	MPDZ NPHP4 ASAP1 NFX1 COBL WDR48	1.79e-04	191	98	6	7220_DN
Drug	5-bromotryptophan	FARSA SCN2A	1.82e-04	5	98	2	CID000096735
Drug	AC1L4WMB	SCN2A COBL	1.82e-04	5	98	2	CID000193595
Drug	Astemizole [68844-77-9]; Down 200; 8.8uM; HL60; HG-U133A	ZNF609 HIPK2 POGZ LYST TGOLN2 RBM15B	1.84e-04	192	98	6	1365_DN
Drug	Tiapride hydrochloride [51012-33-0]; Down 200; 11uM; MCF7; HT_HG-U133A	SETX POGZ FRMD4A CDK13 MARK4 NFX1	1.84e-04	192	98	6	2292_DN
Drug	Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A	ZNF609 ZMYND8 MPDZ LYST FRMD4A ZFR	1.89e-04	193	98	6	3258_DN
Drug	oxaprozin; Down 200; 300uM; MCF7; HT_HG-U133A_EA	ZNF609 MPDZ MED1 COBL ZFR WDR48	1.95e-04	194	98	6	971_DN
Drug	H-89, Dihydrochloride; Up 200; 0.5uM; PC3; HT_HG-U133A	HIPK2 MED1 TGOLN2 UBE2O ZFR EML1	1.95e-04	194	98	6	6921_UP
Drug	Retrorsine [480-54-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A	SP1 ZNF609 POGZ RTF1 NFX1 AFF4	1.95e-04	194	98	6	2784_DN
Drug	(-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A	ZMYND8 HIPK2 MPDZ ARID1A FRMD4A MARK4	1.95e-04	194	98	6	3539_DN
Drug	SC-560; Up 200; 10uM; MCF7; HT_HG-U133A	ZNF609 STAG1 MPDZ NPHP4 ADAM22 WDR48	2.00e-04	195	98	6	6913_UP
Drug	Harmaline hydrochloride dihydrate [6027-98-1]; Up 200; 14uM; MCF7; HT_HG-U133A	ZNF609 ZMYND8 HIPK2 ADAM22 MARK4 AHR	2.00e-04	195	98	6	2805_UP
Drug	arachidonyl trifluoromethyl ketone; Up 200; 10uM; MCF7; HG-U133A	ZNF609 ARID1A CCNT2 COBL AFF1 WDR48	2.00e-04	195	98	6	327_UP
Drug	Risperidone [106266-06-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A	SP1 ZMYND8 HIPK2 POGZ FRMD4A MARK4	2.00e-04	195	98	6	3508_DN
Drug	estradiol; Down 200; 0.01uM; PC3; HT_HG-U133A	ZNF609 ZMYND8 ADAM22 CDK13 COBL FYB1	2.00e-04	195	98	6	5910_DN
Drug	Asiaticoside [16830-15-2]; Down 200; 4.2uM; MCF7; HT_HG-U133A	TNRC6B MPDZ RFX7 ASAP1 NFX1 WDR48	2.00e-04	195	98	6	7004_DN
Drug	AG-028671 [847803-03-6]; Up 200; 10uM; PC3; HT_HG-U133A	ZNF609 GREB1L CCNT2 CDK13 NFX1 FYB1	2.00e-04	195	98	6	6557_UP
Drug	Tocainide hydrochloride; Down 200; 17.4uM; PC3; HT_HG-U133A	ZMYND8 ADAM22 GREB1L NFX1 R3HDM1 FYB1	2.06e-04	196	98	6	4256_DN
Drug	PNU-0230031 [267429-39-0]; Up 200; 1uM; PC3; HT_HG-U133A	HIPK2 GREB1L FRZB COBL AFF1 ZFR	2.06e-04	196	98	6	4291_UP
Drug	sodium 4-phenylbutyrate; Up 200; 1000uM; HL60; HG-U133A	ZNF609 POGZ MED1 ADAM22 ZC2HC1A AHR	2.06e-04	196	98	6	411_UP
Drug	Baclofen (R,S) [1134-47-0]; Down 200; 18.8uM; HL60; HG-U133A	TTF2 SPECC1L MED1 ARID1A FARSA ZFR	2.06e-04	196	98	6	2036_DN
Drug	Nalbuphine hydrochloride [23277-43-2]; Up 200; 10.2uM; HL60; HG-U133A	CEP350 CCNT2 ZC2HC1A TNFAIP6 R3HDM1 FYB1	2.06e-04	196	98	6	1379_UP
Drug	Lomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; PC3; HT_HG-U133A	ZNF609 ADAM22 GREB1L FRZB MARK4 PLG	2.06e-04	196	98	6	4281_UP
Drug	Mephentermine hemisulfate [1212-72-2]; Down 200; 9.4uM; PC3; HT_HG-U133A	ZMYND8 GJC1 GREB1L CCNT2 CDK13 COBL	2.06e-04	196	98	6	3685_DN
Drug	Proadifen hydrochloride [62-68-0]; Up 200; 10.2uM; PC3; HT_HG-U133A	ZNF609 SETX ZMYND8 TNRC6B ARID1A CCNT2	2.06e-04	196	98	6	5807_UP
Drug	Isosorbide dinitrate [87-33-2]; Down 200; 17uM; MCF7; HT_HG-U133A	TTF2 SP1 ZNF609 ZMYND8 TNRC6B ADAM22	2.06e-04	196	98	6	6038_DN
Drug	Ethambutol dihydrochloride [1070-11-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A	MAGEB2 ZNF609 ADAM22 FRMD4A CDK13 AFF4	2.11e-04	197	98	6	4120_UP
Drug	Amethopterin (R,S) [59-05-2]; Up 200; 8.8uM; MCF7; HT_HG-U133A	SEMG2 ARID1A GREB1L FRMD4A R3HDM1 FYB1	2.11e-04	197	98	6	3214_UP
Drug	alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A	HIPK2 MPDZ ASAP1 TGOLN2 ZFR WDR48	2.11e-04	197	98	6	6930_DN
Drug	Flurandrenolide [1524-88-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A	SP1 ZMYND8 CDK13 MARK4 EML1 AFF4	2.11e-04	197	98	6	4702_DN
Drug	Ramipril [87333-19-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A	ZNF609 ZMYND8 POGZ ADAM22 CCNT2 MARK4	2.11e-04	197	98	6	3572_DN
Drug	Medrysone [2668-66-8]; Up 200; 11.6uM; PC3; HT_HG-U133A	PARP8 ZMYND8 HOXA3 GREB1L CDK13 FYB1	2.11e-04	197	98	6	4266_UP
Drug	Pancuronium bromide [15500-66-0]; Down 200; 5.4uM; HL60; HT_HG-U133A	SP1 ZNF609 HIPK2 GRAMD1B UBE2O MARK4	2.11e-04	197	98	6	2909_DN
Drug	Nitrofural [59-87-0]; Up 200; 20.2uM; MCF7; HT_HG-U133A	ZMYND8 POGZ ARID1A LYST NFX1 R3HDM1	2.11e-04	197	98	6	5321_UP
Drug	Erythromycin [114-07-8]; Up 200; 5.4uM; MCF7; HT_HG-U133A	MAGEB2 MCPH1 CAMK2B LYST ADAM22 MARK4	2.11e-04	197	98	6	1510_UP
Drug	Todralazine hydrochloride [3778-76-5]; Up 200; 14.8uM; MCF7; HT_HG-U133A	ZNF609 HIPK2 ADAM22 RTF1 CEP350 FRMD4A	2.11e-04	197	98	6	5512_UP
Drug	Clomipramine hydrochloride [17321-77-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A	ZNF609 HIPK2 POGZ LYST MARK4 NFX1	2.11e-04	197	98	6	3182_DN
Drug	Tetracycline hydrochloride [64-75-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A	SP1 ZMYND8 MED1 RFX7 ARID1A ADAM22	2.11e-04	197	98	6	6233_UP
Drug	Dihydrostreptomycin sulfate [5490-27-7]; Up 200; 2.8uM; MCF7; HT_HG-U133A	MCPH1 CAMK2B HOXA3 FRMD4A MARK4 FYB1	2.11e-04	197	98	6	2237_UP
Drug	Cefixime [79350-37-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A	CAMK2B ZMYND8 HIPK2 CCNT2 CDK13 FYB1	2.11e-04	197	98	6	3247_UP
Drug	novobiocin sodium, USP; Up 200; 100uM; MCF7; HG-U133A	CLASP1 GJC1 ASAP1 CCNT2 AHR WDR48	2.17e-04	198	98	6	342_UP
Drug	Tracazolate hydrochloride [41094-88-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A	CAMK2B ADAM22 GREB1L FRMD4A CDK13 MARK4	2.17e-04	198	98	6	4964_UP
Drug	Nitrarine dihydrochloride [20069-05-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A	SP1 SNX16 ADAM22 CEP350 MARK4 AFF4	2.17e-04	198	98	6	4705_DN
Drug	Tyloxapol [25301-02-4]; Up 200; 4uM; MCF7; HT_HG-U133A	ZNF609 GJC1 HUWE1 CDK13 R3HDM1 FYB1	2.17e-04	198	98	6	5672_UP
Drug	PHA-00816795 [212631-79-3]; Down 200; 10uM; PC3; HT_HG-U133A	TTF2 ZNF609 GJC1 MPDZ MED1 TGOLN2	2.17e-04	198	98	6	7076_DN
Drug	Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A	ZNF609 ATRX MED1 CEP350 FRMD4A MARK4	2.17e-04	198	98	6	3292_DN
Drug	(+/-)-thalidomide; Down 200; 100uM; MCF7; HG-U133A	MAGEB2 CAMK2B SH3BP1 GJC1 LYST AHR	2.17e-04	198	98	6	266_DN
Drug	Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; PC3; HT_HG-U133A	ZNF609 CAMK2B MPDZ MARK4 R3HDM1 FYB1	2.17e-04	198	98	6	4681_UP
Drug	Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A	SP1 ZMYND8 MPDZ MED1 ASAP1 CCNT2	2.17e-04	198	98	6	1479_DN
Drug	Methazolamide [554-57-4]; Down 200; 17uM; MCF7; HT_HG-U133A	STAG1 TNRC6B FASTKD5 NPHP4 RTF1 CCNT2	2.23e-04	199	98	6	6268_DN
Drug	Ticarcillin sodium [4697-14-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A	SP1 LYST ADAM22 NFX1 AFF1 R3HDM1	2.23e-04	199	98	6	7185_UP
Drug	Metyrapone [54-36-4]; Up 200; 17.6uM; PC3; HT_HG-U133A	SEMG2 ARPP21 CAMK2B HUWE1 NFX1 FYB1	2.23e-04	199	98	6	4606_UP
Drug	CP-320650-01 [172079-28-6]; Down 200; 10uM; PC3; HT_HG-U133A	MAGEB2 ZMYND8 HUWE1 GREB1L MARK4 FYB1	2.29e-04	200	98	6	3822_DN
Drug	Topiroxostat	SP1 FYB1	2.72e-04	6	98	2	CID005288320
Drug	InsS6	SEMG2 LYST NFX1	2.89e-04	30	98	3	CID000065302
Disease	neutrophil percentage of leukocytes	SP1 TNRC6B ARID1A TGOLN2 RTF1 HOXA3 UBE2O ZC2HC1A CDK13 MARK4 TMEM131	5.37e-06	610	97	11	EFO_0007990
Disease	plasminogen activator inhibitor 1 measurement	KRT74 PARP8 RFX7 PLG	3.06e-05	54	97	4	EFO_0004792
Disease	lymphocyte percentage of leukocytes	RFX7 ARID1A TGOLN2 HOXA3 GRAMD1B UBE2O ZC2HC1A CDK13 MARK4 AFF1	6.83e-05	665	97	10	EFO_0007993
Disease	free cholesterol in large VLDL measurement	ANKRD31 ARID1A AFF1 PLG	7.61e-05	68	97	4	EFO_0022265
Disease	coronary artery disease	ANKRD31 STAG1 PARP8 SPECC1L ANKRD50 SRFBP1 RTF1 CRACD KIAA1217 MARK4 EML1 PLG ARHGAP21	1.45e-04	1194	97	13	EFO_0001645
Disease	Growth Disorders	ATRX AHR AFF4	2.27e-04	36	97	3	C0018273
Disease	sleep duration, low density lipoprotein cholesterol measurement	ANKRD31 ATXN7L2 PLG R3HDM1	2.36e-04	91	97	4	EFO_0004611, EFO_0005271
Disease	Spastic Paraplegia	LYST WDR48	3.79e-04	9	97	2	C0037772
Disease	Silicosis	AHR PDZRN4	3.79e-04	9	97	2	C0037116
Disease	Congenital Heart Defects	HOXA3 AHR AFF4	4.14e-04	44	97	3	C0018798
Disease	Uterine leiomyoma, estrogen-receptor negative breast cancer	MCM8 TNRC6B	4.73e-04	10	97	2	EFO_1000650, HP_0000131
Disease	metabolic syndrome	CAMK2B ARID1A AFF1 PLG WDR48	5.29e-04	200	97	5	EFO_0000195
Disease	triglycerides in medium HDL measurement	STAG1 AFF1 PLG	7.56e-04	54	97	3	EFO_0022321
Disease	phospholipids:total lipids ratio	ANKRD31 STAG1 ARID1A AFF1 PLG	9.36e-04	227	97	5	EFO_0020946
Disease	lymphocyte count	TTF2 TNRC6B RFX7 LYST HOXA3 GRAMD1B UBE2O ZC2HC1A CDK13 ZNF644 MARK4 ZNF638 AFF1	1.01e-03	1464	97	13	EFO_0004587
Disease	triglycerides to total lipids in large HDL percentage	ARID1A AFF1 PLG	1.03e-03	60	97	3	EFO_0022330
Disease	triglycerides in small VLDL measurement	ARID1A AFF1 PLG	1.08e-03	61	97	3	EFO_0022145
Disease	free cholesterol in very large VLDL measurement	ANKRD31 ARID1A AFF1	1.08e-03	61	97	3	EFO_0022274
Disease	triglycerides in medium LDL measurement	ARID1A AFF1 PLG	1.13e-03	62	97	3	EFO_0022322
Disease	phospholipids in large VLDL measurement	ARID1A AFF1 PLG	1.13e-03	62	97	3	EFO_0022169
Disease	platelet crit	ANKRD31 ATRX STAG1 ARID1A ITGAD FARSA CDK13 MARK4 AFF1 FYB1	1.16e-03	952	97	10	EFO_0007985
Disease	mean reticulocyte volume	SP1 CLASP1 SPECC1L CEP350 KIAA1217 MARK4 ZNF638 AFF1 ARHGAP21	1.28e-03	799	97	9	EFO_0010701
Disease	triglycerides in small LDL measurement	ARID1A AFF1 PLG	1.30e-03	65	97	3	EFO_0022323
Disease	triglycerides to phosphoglycerides ratio	ARID1A AFF1 PLG	1.48e-03	68	97	3	EFO_0022327
Disease	Uterine leiomyoma, estrogen-receptor positive breast cancer	MCM8 TNRC6B	1.58e-03	18	97	2	EFO_1000649, HP_0000131
Disease	cholesteryl ester measurement	ANKRD31 STAG1 ARID1A AFF1 PLG	1.62e-03	257	97	5	EFO_0010351
Disease	triglycerides to total lipids in small HDL percentage	ARID1A AFF1 PLG	1.74e-03	72	97	3	EFO_0022336
Disease	monounsaturated fatty acids; 16:1, 18:1 measurement	STAG1 AFF1 PLG	2.19e-03	78	97	3	EFO_0022187
Disease	QRS duration, response to sulfonylurea	LRFN5 ZNF638	2.59e-03	23	97	2	EFO_0005055, EFO_0007922
Disease	cognitive function measurement	ARPP21 ATXN7L2 CLASP1 GJC1 FRMD4A KIAA1217 SCN2A ZNF638 ZFR TMEM131 MYO18B ARHGAP21	2.60e-03	1434	97	12	EFO_0008354
Disease	unipolar depression, neuroticism measurement	KIAA1217 ARHGAP21	2.82e-03	24	97	2	EFO_0003761, EFO_0007660
Disease	serum gamma-glutamyl transferase measurement	ARPP21 ATRX STAG1 SPECC1L ARID1A AFF1 TSHZ1 CGNL1 ARHGAP21	3.17e-03	914	97	9	EFO_0004532

Protein segments in the cluster

Peptide	Gene	Start	Entry
NGNRSSTRSSSTKGK	PRPF4B	156	Q13523
TKNGTSGKDSATTST	AHR	431	P35869
KQGQSQAASSSSVTS	CCNT2	466	O60583
KSRLSQATKNSGSSQ	SH3BP1	156	Q9Y3L3
GVSTNSASSSKKRSN	ADAM22	791	Q9P0K1
TQGISSTSSKSSKGG	C13orf42	111	A0A1B0GVH6
SSTKRSTSTGNKESS	SPECC1L	106	Q69YQ0
SKVQSLTIKSNSSGS	ANKRD50	1126	Q9ULJ7
AAKASNTSTPTKGNT	CDK13	486	Q14004
TKGNTETSASASQTN	CDK13	496	Q14004
TSSTRSTGKLSKAGS	ARPP21	396	Q9UBL0
STGKLSKAGSESSSS	ARPP21	401	Q9UBL0
SSQSGRSGGKNSKKS	GRAMD1B	66	Q3KR37
STKTSSREKGQGSRS	ATXN7L2	141	Q5T6C5
STSQSQKRSSGLQSG	AFF4	116	Q9UHB7
SQSSSLKSSSNSNKE	AFF4	836	Q9UHB7
LKSSSNSNKETSGSS	AFF4	841	Q9UHB7
NSNKETSGSSKNSSS	AFF4	846	Q9UHB7
TSGSSKNSSSTSKQK	AFF4	851	Q9UHB7
QSFGQTGKRSKSSSK	R3HDM1	61	Q15032
SSEGTKESSSNSLSN	RBM15B	641	Q8NDT2
SSSGQSSKESTSTKA	PDZRN4	781	Q6ZMN7
SKKTSSQSNSSSEGS	RIMBP3B	776	A6NNM3
SKKTSSQSNSSSEGS	RIMBP3C	776	A6NJZ7
STAKLSSTTQNNTGK	INTS12	306	Q96CB8
TKSGSNTSSSNGDTK	LRFN5	401	Q96NI6
NVGTSSSAASSLKKQ	ARID1A	1081	O14497
SSSSGSGQQDTIKKA	ANKRD31	1671	Q8N7Z5
SSKSSNTSQSQKKGQ	PARP8	761	Q8N3A8
ATTSTATSKNSGSNS	HIPK2	166	Q9H2X6
EKNASSSQASTSTKS	MAGEB2	91	O15479
TQNKGTTSKISNSSE	MCPH1	561	Q8NEM0
ALKKQSSSSTTSQGG	NELFE	31	P18615
SISNSKGQKTKSSED	MCM8	361	Q9UJA3
TKQKTSSSSSGESCA	HOXA3	166	O43365
KNKSSSGSSVATSGQ	PPP1R2C	16	O14990
NATQSGTKTSASKTG	KIAA1109	4101	Q2LD37
GSQALKSSQGSRSSS	C1orf198	161	Q9H425
SRSGRKSKNNNKSSS	ING3	296	Q9NXR8
VKTKTVSSSNGGESS	PCNP	31	Q8WW12
FHKTSSGNSTSKGQT	FYB1	371	O15117
SGSKPKSQQTSFQSS	NFX1	76	Q12986
SSSSLNSATSSQSKK	DNAJC21	511	Q5F1R6
NGVSSSSTADKSQKQ	GREB1L	1136	Q9C091
SSLFGSKSASSKNKS	HUWE1	2261	Q7Z6Z7
QLSSSSTSTKSAKSG	IQSEC3	596	Q9UPP2
STSTKSAKSGSEASA	IQSEC3	601	Q9UPP2
SRKVVSSSKTSSGSQ	NPHP4	321	O75161
SASSENNKASSSKAT	ITGAD	896	Q13349
SSGSQESDSSQSAKK	FRMD4A	371	Q9P2Q2
SSKRNTKEIQSGSSS	ATRX	1141	P46100
KTSAAAGSSSRKGSS	HECTD1	1371	Q9ULT8
SKTSSSKASTLQLGS	FASTKD5	81	Q7L8L6
GKKAFTPSSNSTSQA	IFT46	281	Q9NQC8
GTQQDSSGKRTLSTS	ICE1	1826	Q9Y2F5
TQKSRSSQNSKAGSY	CGNL1	26	Q0VF96
KVGSKAGSNKSTASS	GJC1	371	P36383
QKFSDGGTETSKQST	CRACD	726	Q6ZU35
SGKQSTSSQEASSAS	COBL	996	O75128
QSAASSRSSTSSKGK	CEP350	1161	Q5VT06
LSTQTSSGSSTLSKK	ASAP1	811	Q9ULH1
ATQSKKQNSLGSSDT	LYST	2141	Q99698
KGTSHSKGQRSSSST	MARK4	401	Q96L34
NRTGSTSSSSSGKKN	EML1	156	O00423
TSSSSSGKKNSESKP	EML1	161	O00423
TLNKSSQGSSSSTQS	ZMYND8	1081	Q9ULU4
RSKSSSSNNSSHSPK	S1PR3	336	Q99500
DKSKVSTSGSSVDSS	MED1	1361	Q15648
STSGSSVDSSKKTSE	MED1	1366	Q15648
NKTASSGSSDKDSSA	RTF1	131	Q92541
TNSTKNSAAATSPKG	CAMK2B	356	Q13554
SKGSAFSTSISKQET	FARSA	176	Q9Y285
SKKTSSQSNSSSEGS	RIMBP3	776	Q9UFD9
VSSSGAQNSDSTKKT	POGZ	71	Q7Z3K3
AQNGSSSKATPSTAK	KIAA1217	1926	Q5T5P2
TRSSEKSSGNCSKGT	SETX	501	Q7Z333
GGKSTQKDVSQSSIS	SEMG2	481	Q02383
SSTNGSNGSESSKNR	SP1	126	P08047
RGTSSTTTTGKKCQS	PLG	386	P00747
QSSSPQKQTSSGTKS	SRSF12	196	Q8WXF0
DTSSKTHSNSQQGTS	AFF1	406	P51825
AAASAKSKVSSSSGT	CLASP1	606	Q7Z460
DDSKSNLNTSGKTTS	CNOT2	296	Q9NZN8
KGSTSKSGSEAQTTK	TGOLN2	106	O43493
SKSSQGKNTSTTSTG	TNFAIP6	251	P98066
GKNTSTTSTGNKNFL	TNFAIP6	256	P98066
NNTVTTSSLSGNKDS	WDR48	156	Q8TAF3
SGSSTSESLESSSKK	MPDZ	1836	O75970
ATGTTSKKNSSQDDL	RPAP3	471	Q9H6T3
SDSSNSDSTQSQKSG	FRZB	301	Q92765
SQTKKNKGSDSSLSG	SRFBP1	231	Q8NEF9
GVSQSKAGSSTQKTQ	ZIK1	86	Q3SY52
AKVSSNKTGFSSSLG	TMEM131	1676	Q92545
SKEKLNATSSSEGST	SCN2A	1131	Q99250
TTSSQSGSGTSRKKS	UBE2O	501	Q9C0C9
TATASDSKGTSNSSK	ZNF609	386	O15014
DSKGTSNSSKTRAGA	ZNF609	391	O15014
GSSSSKTSSVRNKKG	STAG1	1066	Q8WVM7
SAAKKSESATSNGVT	RFX7	231	Q2KHR2
GTKKGTTTNATSTTT	SAP30BP	226	Q9UHR5
NSKSSSGTRSGSQQI	MYO18B	76	Q8IUG5
GKVSSSSSSLGNKLQ	ZC2HC1A	206	Q96GY0
GSTSQSSSFSKIHKR	ZNF644	666	Q9H582
TTGNSSLNSTSNTKV	ZFR	471	Q96KR1
SKTRATQGQGQSSSK	TTC16	721	Q8NEE8
GSVSTSSNSSKGQLE	SNX16	31	P57768
SQKSSEDSGSRKDSS	ARHGAP21	911	Q5T5U3
AKTKSDSGTAAQTSL	UIMC1	541	Q96RL1
LKKSGSTTSTNDASQ	TSHZ1	136	Q6ZSZ6
SVAKVNKSTGKSASS	ZNF638	801	Q14966
TSNKGKGSQCQSASS	TNRC6B	236	Q9UPQ9
RPSASSQEKSSGKSQ	TTF2	231	Q9UNY4
SVGQASKGTSKATSE	ZNF518B	691	Q9C0D4
SSGSTQSGQTKTTEA	KRT74	491	Q7RTS7
TASKQSTASKQSTAS	MYOM1	191	P52179
STASKQSTASKQSTA	MYOM1	196	P52179